Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Denali Capital Acquisition Corp DECA

Denali Capital Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It has not selected any potential business combination target or initiated any substantive discussions, directly or indirectly, with any... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:DECA)

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

GlobeNewswire 4 hours ago

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

GlobeNewswire 4 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DECA, PWUP, MNTX, RFL on Behalf of Shareholders

Accesswire September 23, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of DECA, PWUP and EVGR

Accesswire September 23, 2024

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

GlobeNewswire September 11, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of DECA, PWUP and EVGR

Accesswire September 11, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders

PR Newswire September 4, 2024

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

GlobeNewswire September 3, 2024

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

GlobeNewswire September 3, 2024

Opinion & Analysis (NDAQ:DECA)

No current opinion is available.

Bullboard Posts (NDAQ:DECA)